From the Literature

Published: Nov 2001

Theodossiades G, Tsevrenis N, Nomikou E, Dadiotis L, Kontopoulou-Griva I

Surgery-associated acquired hemophilia A.
Ann Hematol 2001;80(11):691-693.

#

NATA REVIEW:
This article raises awareness of the occurrence of acquired FVIII inhibitor postoperatively....
REVIEW by:

Published: Nov 2001

Goicoechea M, Caramelo C, Rodriguez P, et al.

Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis.
Nephrol Dial Transplant 2001;16(11):2188-2193.

#

NATA REVIEW:
This is a very interesting point that is probably unknown to many clinicians. Personally, I was not aware...
REVIEW by:

Published: Nov 2001

Handel M, Winkler J, Hornlein RF, Northoff H, Heeg P, Sell S

Time-related changes of collected shed blood in autologous retransfusion after total knee arthroplasty.
Arch Orthop Trauma Surg 2001;121(10):557-560.

#

NATA REVIEW:
The prolonged collection of drained blood is problematic due the risk of bacterial contamination...
REVIEW by:

Published: Sep 2001

Andreasen AS, Schmidt H, Jarlov JO, Skov R

Autologous transfusion of shed mediastinal blood after coronary artery bypass grafting and bacterial contamination.
Ann Thorac Surg 2001;72(4):1327-1330.

#

NATA REVIEW:
A good article to read. Many physicians retransfuse unwashed blood, but most experts prefer washed blood...
REVIEW by:
Gombotz H.

Published: Sep 2001

Wise MW, O’Leary JP

The origins of blood transfusion: the later phase.
Am Surg 2001;67(10):1011-1013.

#

NATA REVIEW:
...
REVIEW by:

Published: Sep 2001

Romero Castro R, Barroso Relinque N, Caunedo Alvarez AC, et al.

Use of recombinant factor VII in hepatology.
Rev Esp Enferm Dig 2001;93(10):664-668.

#

NATA REVIEW:
This article starts with a general overview on mechanism of action, uses and safety of rFVIIa...
REVIEW by:

Published: Sep 2001

Steinitz D, Harvey EJ, Leighton RK, Petrie DP

Is homologous blood transfusion a risk factor for infection after hip replacement?
Can J Surg 2001;44(5):355-358.

#

NATA REVIEW:
Note: It is difficult to ascertain transfusion as a factor entirely separate from co-morbidity. -...
REVIEW by:

Published: Sep 2001

Hudson JQ, Comstock TJ

Considerations for optimal iron use for anemia due to chronic kidney disease.
Clin Ther 2001;23(10):1637-1671.

#

NATA REVIEW:
It is certainly of great value to have an overview about different iron regimens in combination...
REVIEW by:

Published: Sep 2001

Rubin GL, Schofield WN, Dean MG, Shakeshaft AP

Appropriateness of red blood cell transfusions in major urban hospitals and effectiveness of an intervention.
Med J Aust 2001;175(7):354-358.

#

NATA REVIEW:
The article describes a too liberal indication for RBC transfusions if recent knowledge on...
REVIEW by:
Kretschmer V.

Published: Sep 2001

Molenaar IQ, Legnani C, Groenland TH, et al.

Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect.
Liver Transplant 2001;7(10):896-903.

#

NATA REVIEW:
This study supports the hypothesis that aprotinin is an anticoagulant which prolongs the aPTT...
REVIEW by:
W. Dietrich

Pages